March 26, 2026
6:00PM - 6:45PM EST

Minimal Resident Disease (MRD) as an Endpoint in the Context of Multiple Myeloma

Zoom

Cindy Herrera, PharmD, BCOP is a senior medical science liaison at Bristol Myers Squibb, focused on multiple myeloma and lymphoma for the past 5 years. Previously, she was a residency trained clinical pharmacist, working with bone marrow transplant and heme malignancy patients at Northwestern Medicine in Chicago, IL for eight years while also working as an adjunct associate clinical professor at Purdue University School of Pharmacy. She completed her PGY1 at Northwestern, PGY2, at Dana Farber Cancer Institute, and Doctor of Pharmacy at Purdue University.